VICTORY against Monsanto achieved: Chemical giant forced to pay out over $1.5 billion in Roundup verdict
By Ethan Huff // Nov 22, 2023

Three former users of Roundup weed killer have won more than $1.5 billion in a judgment against Monsanto, now a unit of Bayer AG, that a Missouri jury says must pay its victims for the glyphosate-based herbicide giving them cancer.

Jurors in state court in Jefferson City awarded James Draeger, Valerie Gunther and Dan Anderson a total of $61.1 million in actual damages along with another $500 million each in punitive damages over claims that using Roundup on their lawns and gardens caused them to develop non-Hodgkin lymphoma.

The suit is one of many in recent days in which juries have ruled against Monsanto over claims concerning the carcinogenic properties of its Roundup formula. This latest suit is one of the largest to be handed down against a U.S.-based corporate defendant this year.

(Related: In 2021, a court ruled that Monsanto showed "willful" disregard for human safety by selling cancer-causing glyphosate.)

Will Monsanto survive the litigatory pressure?

Though Monsanto has won other similar such cases in the past, the fact that it lost this big one along with numerous others recently, has caused speculation that the now-German-owned drug and agriculture chemical company may need to alter its legal strategy.

The jury, based in Cole County, Mo., ruled that Monsanto is liable for claims of negligence, design defects and failing to warn plaintiffs of the potential health damages of using Roundup, the primary active ingredient of which is glyphosate.

Each of the three plaintiffs was diagnosed with non-Hodgkin lymphoma that is said to have been caused by the simple use of Roundup on their family properties. The weed killer is highly toxic, we now know, and Monsanto is known for hiding and covering up the damning science against its products.

Monsanto is appealing the ruling, which could end up resulting in reduced punitive damages. It all depends on what happens and whether or not the case makes it to the Supreme Court, which reportedly will not allow punitive damages to be this high based on court guidance.

Bayer, which purchased Monsanto a few years back, continues to claim that decades of studies support the safe use of Roundup.

The case marks the fourth straight loss for Bayer in court this year. Union Investment, one of Bayer's top 10 shareholders, recently called on the company to try to engage more directly with plaintiffs to settle cases rather than see them through to court.

Meanwhile, the plaintiffs are celebrating the victory, as is their lawyer, Bart Rankin, who said in a statement that this is just the first case among many to be won on behalf of thousands of plaintiffs all across the country.

In many ways, Monsanto has turned out to be a toxic asset for Bayer, which everyone cringed at when the company took over the chemical giant. With so much evidence floating around out there about the dangers of glyphosate, it is almost shocking that Bayer made the decision to buy at all.

Nevertheless, suits against Bayer continue to flood the courts, and the company has said in a recent statement that it plans to present stronger arguments in the appeal that it says will overturn the judgment.

"It said in the recent trials that have gone against the company, courts have improperly permitted plaintiffs to misrepresent the European Union's renewal process for glyphosate and the safety assessment by the U.S. Environmental Protection Agency," Reuters reported about the matter.

Last week, the EU Commission said it would renew approval for glyphosate based on the safety assessments of the European Food Agency and European Chemicals Agency following the failure of EU member states to provide a clear opinion one way or another about the herbicide's continued use.

More of the latest news about the downfall of the chemical industry can be found at Collapse.news.

Sources for this article include:

Bloomberg.com

NaturalNews.com

Reuters.com



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.